MOH
- Marketing authorisation holder: FOREST LABS
- Status: likely_approved
Betaprone (PROPIOLACTONE) regulatory status in United Arab Emirates.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH has authorised it.
FOREST LABS holds the UAE marketing authorisation.